Old Web
English
Sign In
Acemap
>
authorDetail
>
Jingxian Shu
Jingxian Shu
Central South University
Internal medicine
Medicine
Diabetes mellitus
Endocrinology
Cardiology
4
Papers
38
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Hepatic leukocyte immunoglobulin‐like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1‐TRAF6 pathway
2018
Hepatology
Yao Lu
Zhou Jiang
Haijiang Dai
Rujia Miao
Jingxian Shu
Haotian Gu
Xing Liu
Zhijun Huang
Guoping Yang
Alex F. Chen
Hong Yuan
Ying Li
Jingjing Cai
Show All
Source
Cite
Save
Citations (23)
Regulator of G Protein Signaling 6 Facilities Cardiac Hypertrophy by Activating Apoptosis Signal–Regulating Kinase 1–P38/c‐JUN N‐Terminal Kinase 1/2 Signaling
2018
Journal of the American Heart Association
Zhijun Huang
Jingxian Shu
Weihong Jiang
Mengqing Jiang
Yao Lu
Haijiang Dai
Nana Xu
Hong Yuan
Jingjing Cai
Show All
Source
Cite
Save
Citations (5)
A12472 Effects of intensive blood pressure treatment on cardiovascular and renal outcomes in old people with chronic kidney disease
2018
Journal of Hypertension
Jingfeng Lou
Hong Yuan
Yao Lu
Jingxian Shu
Nana Xu
Show All
Source
Cite
Save
Citations (0)
Readability and Content Assessment of Informed Consent Forms for Phase II-IV Clinical Trials in China.
2016
PLOS ONE
Gaiyan Wen
Xinchun Liu
Lihua Huang
Jingxian Shu
Nana Xu
Ruifang Chen
Zhijun Huang
Guoping Yang
Xiaomin Wang
Yuxia Xiang
Yao Lu
Hong Yuan
Show All
Source
Cite
Save
Citations (10)
1